RADIOLOGÍA Y MEDICINA FÍSICA EN PROCESOS ONCOLÓGICOS
![Foto de RADIOLOGÍA Y MEDICINA FÍSICA EN PROCESOS ONCOLÓGICOS](/img/grupo.png)
![Foto de Hospital Ramón y Cajal](/img/noimage_org.png)
Hospital Ramón y Cajal
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (22)
2024
-
Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?
Clinical Genitourinary Cancer, Vol. 22, Núm. 1, pp. 56-66
-
Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalities
Clinical and Translational Radiation Oncology, Vol. 45
-
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial
European urology oncology, Vol. 7, Núm. 3, pp. 462-468
-
Radiotherapy for Metastatic Epidural Spinal Cord Compression with Increased Doses: Final Results of the RAMSES-01 Trial
Cancers, Vol. 16, Núm. 6
2023
-
Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 50, Núm. 8, pp. 2486-2500
-
Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer
World Journal of Urology, Vol. 41, Núm. 12, pp. 3829-3838
2022
-
Bone health and therapeutic agents in advanced prostate cancer
Frontiers in Bioscience - Landmark, Vol. 27, Núm. 1
-
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial
Radiotherapy and Oncology, Vol. 172, pp. 1-9
-
Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer
Frontiers in Oncology, Vol. 12
-
SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis
Clinical and Translational Oncology, Vol. 24, Núm. 2, pp. 215-226
2021
-
Extreme hypofractionation with sbrt in localized prostate cancer
Current Oncology, Vol. 28, Núm. 4, pp. 2933-2949
-
The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases
European Urology Focus
2020
-
Clinical applications of molecular biomarkers in prostate cancer
Cancers, Vol. 12, Núm. 6, pp. 1-25
2019
-
Impact of rectum and bladder anatomy in intrafractional prostate motion during hypofractionated radiation therapy
Clinical and Translational Oncology, Vol. 21, Núm. 5, pp. 607-614
-
Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): A prospective multicenter study
BMC Cancer, Vol. 19, Núm. 1
-
Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes
Clinical and Translational Oncology, Vol. 21, Núm. 8, pp. 1044-1051
2018
-
Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database
Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 193-200
-
Importance of 68Ga-PSMA PET/CT in hospital practice. View of the radiation oncologist
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 5, pp. 302-314
2016
-
Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272]
Reports of Practical Oncology and Radiotherapy
-
The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort
Clinical and Translational Oncology, Vol. 18, Núm. 10, pp. 1026-1033